For research use only. Not for therapeutic Use.
Sulfisomidin（Cat No.:I013132）is a broad-spectrum sulfonamide antibiotic used in the treatment of bacterial infections, particularly those caused by Gram-positive and Gram-negative organisms. It inhibits bacterial growth by interfering with folic acid synthesis, which is essential for bacterial DNA replication. This bacteriostatic effect makes it effective against a variety of infections, including urinary tract infections, respiratory infections, and gastrointestinal infections. Sulfisomidin is often utilized in combination with other antibiotics to enhance efficacy and prevent resistance. It is suitable for both systemic and localized infections, ensuring optimal therapeutic outcomes in clinical settings.
| Catalog Number | I013132 |
| CAS Number | 515-64-0 |
| Molecular Formula | C₁₂H₁₄N₄O₂S |
| Purity | ≥95% |
| Target | Bacterial |
| Solubility | DMSO: ≥ 30 mg/mL |
| IUPAC Name | 4-amino-N-(2,6-dimethylpyrimidin-4-yl)benzenesulfonamide |
| InChI | InChI=1S/C12H14N4O2S/c1-8-7-12(15-9(2)14-8)16-19(17,18)11-5-3-10(13)4-6-11/h3-7H,13H2,1-2H3,(H,14,15,16) |
| InChIKey | YZMCKZRAOLZXAZ-UHFFFAOYSA-N |
| SMILES | CC1=CC(=NC(=N1)C)NS(=O)(=O)C2=CC=C(C=C2)N |
| Reference | [1]. Bridges JW, et al. Species differences in the metabolism and excretion of sulphasomidine andsulphamethomidine. Biochem J. 1969 Jan;111(2):173-9. |
